INmune Bio Inc (INMB)
Fair Value-1.0% Downside
Fair
Analyst268.4% Upside
Market Cap50.778 M
P/E-1.2x
Yield0.0%
HealthWeak
NASDAQ
Innate Pharma SA (IPHA)
Fair Value-3.8% Downside
Fair
Analyst239.0% Upside
Market Cap166.4 M
P/E-2.9x
Yield0.0%
HealthWeak
NASDAQ
Instil Bio Inc (TIL)
Fair Value24.9% Upside
Undervalued
Analyst-3.6% Downside
Market Cap49.169 M
P/E-1.0x
Yield0.0%
HealthFair
NASDAQ
Inventiva Sa (IVA)
Fair Value-22.6% Downside
Overvalued
Analyst215.3% Upside
Market Cap1.058 B
P/E-2.6x
Yield0.0%
HealthWeak
NASDAQ
Featured in
Overvalued Stocks
Small-Cap Stocks
Invivyd Inc (IVVD)
Fair Value13.4% Upside
Fair
Market Cap168.9 M
P/E-2.3x
Yield0.0%
HealthFair
NASDAQ
Jade Biosciences Inc (JBIO)
Fair Value-31.4% Downside
Overvalued
Analyst123.6% Upside
Market Cap1.267 B
P/E-13.5x
Yield0.0%
HealthGood
NASDAQ
Featured in
Overvalued Stocks
High-Beta Stocks
Small-Cap Stocks
Janux Therapeutics Inc (JANX)
Fair Value26.3% Upside
Undervalued
Analyst132.4% Upside
Market Cap973.3 M
P/E-8.5x
Yield0.0%
HealthFair
NASDAQ
Featured in
Small-Cap Stocks
Jasper Therapeutics Inc (JSPR)
Fair Value11.9% Upside
Fair
Market Cap18.632 M
P/E-0.3x
Yield0.0%
HealthWeak
NASDAQ
Kalaris Therapeutics Inc (KLRS)
Fair Value8.5% Upside
Fair
Analyst346.6% Upside
Market Cap102.8 M
P/E-2.3x
Yield0.0%
HealthFair
NASDAQ
Featured in
High-Beta Stocks
Keros Therapeutics Inc (KROS)
Fair Value37.3% Upside
Undervalued
Analyst103.5% Upside
Market Cap203.2 M
P/E-2.4x
Yield0.0%
HealthWeak
NASDAQ
Kodiak Sciences Inc (KOD)
Fair Value-34.1% Downside
Overvalued
Analyst49.0% Upside
Market Cap2.678 B
P/E-11.8x
Yield0.0%
HealthFair
NASDAQ
Featured in
Overvalued Stocks
High-Beta Stocks
Korro Bio Inc (KRRO)
Fair Value21.7% Upside
Undervalued
Analyst73.9% Upside
Market Cap163.7 M
P/E-1.5x
Yield0.0%
HealthFair
NASDAQ
Featured in
High-Beta Stocks
Kymera Therapeutics Inc (KYMR)
Fair Value-32.2% Downside
Overvalued
Analyst22.0% Upside
Market Cap8.587 B
P/E-27.5x
Yield0.0%
HealthFair
NASDAQ
Featured in
Overvalued Stocks
Lantern Pharma Inc (LTRN)
Fair Value5.9% Upside
Fair
Analyst525.0% Upside
Market Cap35.087 M
P/E-2.2x
Yield0.0%
HealthFair
NASDAQ
Legend Biotech Corp (LEGN)
Fair Value38.1% Upside
Undervalued
Analyst173.5% Upside
Market Cap3.701 B
P/E-14.7x
Yield0.0%
HealthGood
NASDAQ
Liminatus Pharma Inc (LIMN)
Fair Value1.5% Upside
Fair
Market Cap5.305 M
P/E-0.5x
Yield0.0%
HealthWeak
NASDAQ
Longeveron LLC (LGVN)
Fair Value44.6% Upside
Undervalued
Analyst883.5% Upside
Market Cap23.449 M
P/E-1.0x
Yield0.0%
HealthFair
NASDAQ
Lyell Immunopharma Inc (LYEL)
Fair Value0.5% Upside
Fair
Analyst183.6% Upside
Market Cap333.3 M
P/E-1.3x
Yield0.0%
HealthFair
NASDAQ
Featured in
High-Beta Stocks
Small-Cap Stocks
MeiraGTx Holdings PLC (MGTX)
Fair Value-7.9% Downside
Fair
Analyst133.4% Upside
Market Cap1.138 B
P/E-9.6x
Yield0.0%
HealthFair
NASDAQ
Featured in
High-Beta Stocks
High-Growth Small-Cap Stocks
Small-Cap Stocks
Mirum Pharmaceuticals Inc (MIRM)
Fair Value-18.4% Downside
Overvalued
Analyst38.7% Upside
Market Cap6.362 B
P/E-8.1x
Yield0.0%
HealthFair
NASDAQ
Featured in
Overvalued Stocks
Moderna Inc (MRNA)
Fair Value-12.3% Downside
Fair
Analyst-9.6% Downside
Market Cap22.752 B
P/E-7.1x
Yield0.0%
HealthWeak
NASDAQ
Featured in
High-Beta Stocks
Molecular Partners AG ADR (MOLN)
Fair Value-10.2% Downside
Fair
Analyst172.7% Upside
Market Cap152.4 M
P/E-2.1x
Yield0.0%
HealthFair
NASDAQ
Monopar Therapeutics Inc (MNPR)
Fair Value-43.9% Downside
Overvalued
Analyst-2.0% Downside
Market Cap793.5 M
P/E-53.3x
Yield0.0%
HealthGood
NASDAQ
Featured in
Overvalued Stocks
High-Momentum Stocks
Small-Cap Stocks
Monte Rosa Therapeutics Inc (GLUE)
Fair Value-1.8% Downside
Fair
Analyst96.5% Upside
Market Cap1.358 B
P/E-10.1x
Yield0.0%
HealthFair
NASDAQ
Featured in
High-Beta Stocks
High-Beta Momentum
Small-Cap Stocks
MoonLake Immunotherapeutics (MLTX)
Fair Value17.8% Upside
Fair
Analyst59.5% Upside
Market Cap1.481 B
P/E-5.6x
Yield0.0%
HealthWeak
NASDAQ
Featured in
Small-Cap Stocks
Nanobiotix (NBTX)
Fair Value-31.8% Downside
Overvalued
Analyst13.6% Upside
Market Cap1.991 B
P/E-71.9x
Yield0.0%
HealthFair
NASDAQ
Featured in
Overvalued Stocks
Rapid Revenue Growth
NewAmsterdam Pharma Company NV (NAMS)
Fair Value-0.4% Downside
Fair
Analyst87.9% Upside
Market Cap3.221 B
P/E-15.1x
Yield0.0%
HealthFair
NASDAQ
NewcelX AG (NCEL)
Fair Value7.3% Upside
Fair
Analyst546.1% Upside
Market Cap18.574 M
P/E-2.2x
Yield0.0%
HealthFair
NASDAQ
NextCure Inc (NXTC)
Fair Value9.0% Upside
Fair
Analyst281.0% Upside
Market Cap20.878 M
P/E-0.3x
Yield0.0%
HealthFair
NASDAQ
Nkarta Inc (NKTX)
Fair Value49.4% Upside
Undervalued
Analyst415.2% Upside
Market Cap161.7 M
P/E-1.6x
Yield0.0%
HealthFair
NASDAQ
Featured in
High-Beta Stocks
Nurix Therapeutics Inc (NRIX)
Fair Value-0.6% Downside
Fair
Analyst32.6% Upside
Market Cap2.562 B
P/E-7.6x
Yield0.0%
HealthWeak
NASDAQ
Olema Pharmaceuticals Inc (OLMA)
Fair Value-5.4% Downside
Fair
Analyst251.8% Upside
Market Cap1.027 B
P/E-5.5x
Yield0.0%
HealthFair
NASDAQ
Featured in
Small-Cap Stocks
Onkure Therapeutics Inc (OKUR)
Fair Value21.7% Upside
Undervalued
Analyst368.8% Upside
Market Cap165.6 M
P/E-2.9x
Yield0.0%
HealthFair
NASDAQ
Oric Pharmaceuticals Inc (ORIC)
Fair Value-18.5% Downside
Overvalued
Analyst61.2% Upside
Market Cap1.396 B
P/E-9.5x
Yield0.0%
HealthGood
NASDAQ
Featured in
Overvalued Stocks
Small-Cap Stocks
Pasithea Therapeutics Corp (KTTA)
Fair Value28.8% Upside
Undervalued
Analyst566.7% Upside
Market Cap15.371 M
P/E-0.8x
Yield0.0%
HealthFair
NASDAQ
Passage Bio Inc (PASG)
Fair Value22.0% Upside
Undervalued
Analyst236.2% Upside
Market Cap14.852 M
P/E-0.4x
Yield0.0%
HealthFair
NASDAQ
Pharming Group Nv (PHAR)
Fair Value14.6% Upside
Fair
Analyst221.6% Upside
Market Cap758.6 M
P/E81.6x
Yield0.0%
HealthGood
NASDAQ
Featured in
High-Growth Small-Cap Stocks
Small-Cap Stocks
Pmv Pharmaceuticals Inc (PMVP)
Fair Value30.1% Upside
Undervalued
Analyst241.9% Upside
Market Cap62.398 M
P/E-0.8x
Yield0.0%
HealthFair
NASDAQ
Praxis Precision Medicines Inc (PRAX)
Fair Value-25.8% Downside
Overvalued
Analyst91.1% Upside
Market Cap8.644 B
P/E-27.3x
Yield0.0%
HealthFair
NASDAQ
Featured in
Overvalued Stocks
High-Beta Stocks
Precision BioSciences Inc (DTIL)
Fair Value-18.3% Downside
Overvalued
Analyst296.3% Upside
Market Cap187.8 M
P/E-4.3x
Yield0.0%
HealthFair
NASDAQ
Featured in
High-Beta Stocks
Prelude Therapeutics Inc (PRLD)
Fair Value1.3% Upside
Fair
Analyst76.2% Upside
Market Cap448.3 M
P/E-5.8x
Yield0.0%
HealthFair
NASDAQ
Featured in
High-Beta Stocks
Small-Cap Stocks
Propanc Biopharma Inc (PPCB)
Fair Value-11.0% Downside
Fair
Market Cap2.324 M
P/E-0.1x
Yield0.0%
NASDAQ
Quince Therapeutics Inc (QNCX)
Fair Value30.4% Upside
Undervalued
Analyst186.5% Upside
Market Cap26.806 M
P/E-0.8x
Yield0.0%
HealthFair
NASDAQ
Rallybio Corp (RLYB)
Fair Value-11.1% Downside
Fair
Analyst-50.4% Downside
Market Cap84.558 M
P/E-10.9x
Yield0.0%
HealthFair
NASDAQ
Featured in
High-Momentum Stocks
Recursion Pharmaceuticals Inc (RXRX)
Fair Value14.7% Upside
Fair
Analyst128.0% Upside
Market Cap1.757 B
P/E-3.0x
Yield0.0%
HealthFair
NASDAQ
Featured in
High-Beta Stocks
Small-Cap Stocks
Relay Therapeutics Inc (RLAY)
Fair Value-36.9% Downside
Overvalued
Analyst32.4% Upside
Market Cap4.259 B
P/E-15.7x
Yield0.0%
HealthFair
NASDAQ
Featured in
Overvalued Stocks
High-Beta Stocks
RenovoRx Inc (RNXT)
Fair Value22.9% Upside
Undervalued
Analyst563.2% Upside
Market Cap46.903 M
P/E-3.9x
Yield0.0%
HealthGood
NASDAQ
Replimune Group Inc (REPL)
Fair Value5.5% Upside
Fair
Analyst9.7% Upside
Market Cap1.001 B
P/E-3.2x
Yield0.0%
HealthFair
NASDAQ
Featured in
Small-Cap Stocks
Revolution Medicines Inc (RVMD)
Fair Value-33.4% Downside
Overvalued
Analyst5.1% Upside
Market Cap41.129 B
P/E-30.5x
Yield0.0%
HealthFair
NASDAQ
Featured in
Overvalued Stocks
High-Beta Stocks